Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
05/25/2001 | CA2389662A1 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
05/25/2001 | CA2389430A1 Srik a novel cell cycle protein associated with rip3 |
05/25/2001 | CA2389289A1 Mammalian toxicological response markers |
05/25/2001 | CA2388922A1 23 human secreted proteins |
05/25/2001 | CA2388777A1 18 human secreted proteins |
05/25/2001 | CA2359577A1 Antibodies and fv fragment recognizing antigen ior c2 |
05/24/2001 | US20010001712 Causing apoptosis on myeloid cells through binding to the myeloid cells |
05/24/2001 | US20010001710 Biologically pure culture of Bacillus thuringiensis strain PS50B having the identifying characteristics of NRRL B-21656; pesticides |
05/24/2001 | US20010001709 Methods for enhancing the production of viral vaccines in cell culture |
05/23/2001 | EP1101820A1 Pentraxin I and Pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
05/23/2001 | EP1101118A1 Determination of the hydrophobic pulmonary surfactant protein sp-c |
05/23/2001 | EP1101113A1 Cell-signaling assays |
05/23/2001 | EP1100949A1 Fusion products containing insoluble proteinaceous tag |
05/23/2001 | EP1100947A1 Method for the production of an antibiotic agent |
05/23/2001 | EP1100934A1 Herpesvirus preparations and their uses |
05/23/2001 | EP1100929A1 Identification and functional characterization of a novel ribosomal s6 protein kinase |
05/23/2001 | EP1100921A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
05/23/2001 | EP1100919A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
05/23/2001 | EP1100918A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
05/23/2001 | EP1100917A1 Granulocytic ehrlichia genes and uses thereof |
05/23/2001 | EP1100915A2 Fibrous proteins and the production thereof |
05/23/2001 | EP1100913A1 Mekk1 serine threonine kinases -interacting fha forkhead associated domain protein 1 (mif1) |
05/23/2001 | EP1100910A1 Dna encoding a human inhibitor-of-apoptosis protein; hiap3 |
05/23/2001 | EP1100909A2 Dna replication- and repair-associated proteins |
05/23/2001 | EP1100908A2 Human receptor-associated proteins |
05/23/2001 | EP1100907A2 Human cytoskeletal proteins |
05/23/2001 | EP1100906A1 Kdel receptor inhibitors |
05/23/2001 | EP1100902A1 Keratinocyte derived interferon |
05/23/2001 | EP1100899A2 Delta-related polypeptides |
05/23/2001 | EP1100898A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
05/23/2001 | EP1100896A1 Dna encoding snorf33 receptor |
05/23/2001 | EP1100893A1 Nucleic acids encoding proteins involved in sensory transduction |
05/23/2001 | EP1100890A2 Improved transformation efficiency in phage display through modification of a coat protein |
05/23/2001 | EP1100886A1 Tumor necrosis factor-gamma |
05/23/2001 | EP1100882A1 Human protein kinase h2lau20 |
05/23/2001 | EP1100879A1 Pneumococcal nrdg protein |
05/23/2001 | EP1100869A1 98 human secreted proteins |
05/23/2001 | EP1100830A2 Heterominibodies |
05/23/2001 | EP1100828A1 Antibodies against beer spoilage lactic acid bacteria and their diagnostic use |
05/23/2001 | EP1100826A1 Isoforms of human calcium sensing receptor |
05/23/2001 | EP1100825A1 Human mink gene mutations associated with arrhythmia |
05/23/2001 | EP1100822A1 Secreted cysteine rich protein-6 (scrp-6) |
05/23/2001 | EP1100817A1 Endogenous retrovirus tumor associated nucleic acids and antigens |
05/23/2001 | EP1100815A1 Protease susceptibility ii |
05/23/2001 | EP1100813A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb |
05/23/2001 | EP1100811A1 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction |
05/23/2001 | EP1100810A1 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction |
05/23/2001 | EP1100808A1 Prostate derived ets factor |
05/23/2001 | EP1100538A2 Kvlqt1 - a long qt syndrome |
05/23/2001 | EP1100535A1 Targeting pharmaceutical agents to injured tissues |
05/23/2001 | EP1100521A1 C7f2-a novel potassium channel beta-subunit |
05/23/2001 | EP1100513A1 Autoinducer synthase modulating compounds and uses therefor |
05/23/2001 | EP1100429A2 Apoptosis proteins |
05/23/2001 | EP0932622A4 Vitamin d response element binding protein |
05/23/2001 | EP0689600B1 Process to induce the death of tumor cells |
05/23/2001 | EP0623170B1 Vaccines based on streptokinase |
05/23/2001 | EP0572433B1 Antigen-presenting capsid with fusion ms2-coat protein |
05/23/2001 | DE19955408A1 New invertebrate gamma-aminobutyric acid receptor proteins, useful in screening for potential insecticides, for plant protection or medicine, also related nucleic acid |
05/23/2001 | CN1296015A IgG Fab-BPI fusion protein and DNA sequence thereof |
05/23/2001 | CN1296014A Novel human growth arrestin and coding sequence thereof |
05/22/2001 | US6235885 Central nervous system disorders |
05/22/2001 | US6235884 Heparin binding mitogen with homology to epidermal growth factor (EGF) |
05/22/2001 | US6235883 Human monoclonal antibodies to epidermal growth factor receptor |
05/22/2001 | US6235880 Polypeptides; hypoglycemic agent |
05/22/2001 | US6235713 Vascular endothelial growth factor-D (VEGF-D) polypeptides |
05/22/2001 | US6235525 Nucleotide sequence; diagnosis; vaccines; transfected cell line |
05/22/2001 | US6235500 Oxygen-binding heme proteins incorporating circularly-permuted globins |
05/22/2001 | US6235498 Propagating mammalian aggregations; transform aggregates with nucleotide sequences which express insulin and heterologous polypeptide, propagate aggregates |
05/22/2001 | US6235497 Viral vector coding rodent transport protein; for treatment of nervous system disorders |
05/22/2001 | US6235496 Nucleic acid encoding mammalian mu opioid receptor |
05/22/2001 | US6235469 Generation of transcriptional sequences associated with phage envelope protein; incubate and insert nucleotide sequences into expression vector, express gene coded in vector and recover polypeptides |
05/22/2001 | US6235285 An isolated polypeptide comprising a heterologous amino acid sequence fused to specific polynucleotide sequence |
05/22/2001 | US6235284 Synthetic polypeptides belonging to the hepatitis C virus (HCV) and which can be used especially for detecting the latter |
05/22/2001 | CA1341236C Process for producing recombinant human factor viii: c and transformant to be used therefor |
05/22/2001 | CA1341235C Modular assembly of antibody genes, antibodies prepared thereby and use |
05/17/2001 | WO2001035102A2 Diagnosis and treatment of malignant neoplasms |
05/17/2001 | WO2001034833A2 Regulating endogenous inhibitor at atp synthase |
05/17/2001 | WO2001034829A2 Nucleic acid sequence which encodes for an amino acid sequence capable of being cyclized within a cell or cell membrane |
05/17/2001 | WO2001034828A1 Process for producing tripeptides |
05/17/2001 | WO2001034808A2 Method of large-scale production and method of testing of the biological activity of a substance from soybean |
05/17/2001 | WO2001034805A2 Human vanilloid receptor gene |
05/17/2001 | WO2001034802A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
05/17/2001 | WO2001034801A2 Recombinant gelatin in vaccines |
05/17/2001 | WO2001034800A1 19 human secreted proteins |
05/17/2001 | WO2001034799A1 6 human secreted proteins |
05/17/2001 | WO2001034797A1 Method of preparing cell fraction containing hemangioblasts |
05/17/2001 | WO2001034767A2 22 human secreted proteins |
05/17/2001 | WO2001034654A1 Hedgehog fusion proteins and uses |
05/17/2001 | WO2001034653A2 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
05/17/2001 | WO2001034652A1 Antibodies to suberic acid crosslinkers and methods for using the same |
05/17/2001 | WO2001034647A2 Animal collagens and gelatins |
05/17/2001 | WO2001034646A2 Recombinant gelatins |
05/17/2001 | WO2001034644A1 15 human secreted proteins |
05/17/2001 | WO2001034643A1 24 human secreted proteins |
05/17/2001 | WO2001034640A2 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
05/17/2001 | WO2001034638A1 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES |
05/17/2001 | WO2001034629A1 21 human secreted proteins |
05/17/2001 | WO2001034628A1 35 human secreted proteins |
05/17/2001 | WO2001034627A1 28 human secreted proteins |
05/17/2001 | WO2001034626A1 28 human secreted proteins |